Anna Raciborska
Clinical trials sponsored by Anna Raciborska, explained in plain language.
-
New hope for kids with stubborn histiocytosis: vemurafenib dose trial launched
Disease control Recruiting nowThis study is for children with a rare disease called histiocytosis that has not improved with standard treatments and who have a specific gene change (BRAF mutation). The goal is to find the best dose and timing of the drug vemurafenib to control the disease. About 25 children w…
Phase: PHASE2 • Sponsor: Anna Raciborska • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for kids with rare blood disease: trametinib trial opens
Disease control Recruiting nowThis study is for children with a rare blood disorder called histiocytosis that hasn't responded to standard treatments. It tests different doses and timing of the drug trametinib to find the best way to control the disease. The goal is to improve how long children stay free of c…
Phase: PHASE2 • Sponsor: Anna Raciborska • Aim: Disease control
Last updated May 14, 2026 12:02 UTC